廣告
香港股市 將在 1 小時 12 分鐘 開市

  • 恒指

    18,475.92
    +268.82 (+1.48%)
     

  • 國指

    6,547.29
    +110.20 (+1.71%)
     

  • 上證綜指

    3,104.82
    -8.22 (-0.26%)
     

  • 道指

    38,675.68
    +449.98 (+1.18%)
     

  • 標普 500

    5,127.79
    +63.59 (+1.26%)
     

  • 納指

    16,156.33
    +315.33 (+1.99%)
     

  • Vix指數

    13.49
    -1.19 (-8.11%)
     

  • 富時100

    8,213.49
    +41.34 (+0.51%)
     

  • 紐約期油

    78.27
    +0.16 (+0.20%)
     

  • 金價

    2,302.70
    -5.90 (-0.26%)
     

  • 美元

    7.8109
    +0.0006 (+0.01%)
     

  • 人民幣

    0.9264
    0.0000 (0.00%)
     

  • 日圓

    0.0506
    -0.0002 (-0.47%)
     

  • 歐元

    8.4030
    -0.0033 (-0.04%)
     

  • Bitcoin

    64,108.84
    +73.71 (+0.12%)
     

  • CMC Crypto 200

    1,331.15
    +54.17 (+4.24%)
     

Aveanna (AVAH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2 分鐘文章

Aveanna Healthcare (AVAH) reported $478.84 million in revenue for the quarter ended December 2023, representing a year-over-year increase of 6.1%. EPS of -$0.01 for the same period compares to -$0.03 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $464.33 million, representing a surprise of +3.12%. The company delivered an EPS surprise of +50.00%, with the consensus EPS estimate being -$0.02.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

廣告

Here is how Aveanna performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- PDS: $383.45 million versus $371.23 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +6.1% change.

  • Revenue- MS: $41.29 million versus the three-analyst average estimate of $37.10 million. The reported number represents a year-over-year change of +17.5%.

  • Revenue- HHH: $54.10 million compared to the $53.14 million average estimate based on three analysts. The reported number represents a change of -1.1% year over year.

View all Key Company Metrics for Aveanna here>>>

Shares of Aveanna have returned +3.7% over the past month versus the Zacks S&P 500 composite's +4.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Aveanna Healthcare Holdings Inc. (AVAH) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research